Renoprotective Effects of DPP-4 Inhibitors

Diabetic kidney disease (DKD) is the leading cause of end-stage renal disease (ESRD) worldwide. Dipeptidyl peptidase (DPP)-4 inhibitors are widely used in the treatment of patients with type 2 diabetes (T2D). DPP-4 inhibitors reduce glucose levels by inhibiting degradation of incretins. DPP-4 is a u...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Daiji Kawanami (Egilea), Yuichi Takashi (Egilea), Hiroyuki Takahashi (Egilea), Ryoko Motonaga (Egilea), Makito Tanabe (Egilea)
Formatua: Liburua
Argitaratua: MDPI AG, 2021-02-01T00:00:00Z.
Gaiak:
Sarrera elektronikoa:Connect to this object online.
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Internet

Connect to this object online.

3rd Floor Main Library

Aleari buruzko argibideak 3rd Floor Main Library
Sailkapena: A1234.567
Alea 1 Eskuragarri